Fundraising FoxArch Oncology Investors
Portland, US · Founded 2021 · Delaware LLC
Find your way into Arch Oncology Investors
Sign up to see every warm intro you have to Arch Oncology Investors
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arch Oncology Investors team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
NT
Nicholas T WalrodManager
AL
Anthony L ArnerichManager
Reported raises · per SEC filings
Form D private placements$11M disclosed across 1 round · 2021
▶$11MraisedMay 2021 · 40 investors · Biotechnology
▶$11MraisedMay 2021 · 40 investors · Biotechnology
Officers, directors & promoters on the filing
- Nicholas T WalrodExecutive Officer
- Anthony L ArnerichExecutive Officer
- Offering amount
- $11M
- Amount sold
- $11M
- Minimum investment
- $25K
- Placement agents
- Arch Oncology Investors, LLC
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 3C, 3C.1
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Arch Oncology Investors raised?
- Arch Oncology Investors has disclosed $11M raised across 1 round.
- Where is Arch Oncology Investors headquartered?
- Arch Oncology Investors is headquartered in Portland, US.